Tags |
|
|
Links |
|
|
Wiki Articles - SPX: Recreating the April Rally
I stated in last week's article, "Consolidating Gains," that the stock market will sometimes create a self-fulfilling prophesy, because the current SPX rally, whi
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
ch started in October, is similar to the rally that started in April, although the current rally was roughly two weeks ahead of the April rally. SPX continued to
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
follow the "script" last week, while still ahead of the previous rally.
The vertical line in the SPX daily chart below compares similar technical points (above a
The vertical line in the SPX daily chart below compares similar technical points (above a
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
nd below the price chart) between the April and current rallies to show where the current rally is now compared to the previous rally. If the self-fulfilling prop
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
hesy completes, SPX will be in an uptrend for another two months and rise to about 1,300.
SPX traded between two strong support and resistance levels recently, w
SPX traded between two strong support and resistance levels recently, w
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
hich are in the 1,160s and 1,250s (see "SPX Multi-Year Support & Resistance Levels" article). SPX has risen about 70 points over the past month, after holding str
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
ong support levels. Normally, after a steep rise, a period of consolidation takes place. However, SPX may rise into the 1,240s, just below strong resistance, befo
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
e consolidating.
Next week is options expiration week, which is typically volatile. November Max Pain expirations for SPX OEX and QQQQ indicate the market will b
Next week is options expiration week, which is typically volatile. November Max Pain expirations for SPX OEX and QQQQ indicate the market will b
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
e much lower next week, e.g. an SPX 20 point pullback. However, Max Pain doesn't work every month and sometimes the Max Pain point is the highest or lowest level
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
the market can reach.
Consequently, if SPX rises into the 1,240s early next week, it may pullback to 1,225 later in the week. An SPX 1,225 to 1,245 trading range
Consequently, if SPX rises into the 1,240s early next week, it may pullback to 1,225 later in the week. An SPX 1,225 to 1,245 trading range
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
is not a large range over one week. If SPX rises into the 1,240s, it will be near the four-year peaks at 1,246 and 1,243. So, the market may become cautious, sin
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
ce it may believe there's little short-term upside, which may generate greater volatility.
The catalysts for the rally have been falling oil prices, a strong Tre
The catalysts for the rally have been falling oil prices, a strong Tre
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
asury auction, and slightly better than expected economic data. Oil fell below $60 a barrel in mid-October, for the first time in about three months, and may cont
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
inue the downtrend towards $50. Strong support in U.S. Treasury bonds by foreigners boosts investor confidence. Recent economic data suggest a continuation of abo
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
e trend growth with tame inflation, at least for several more months.
There are many important economic reports next week--Monday: None, Tuesday: PPI, Retail Sal
There are many important economic reports next week--Monday: None, Tuesday: PPI, Retail Sal
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
es, Business Inventories, and Empire State Index, Wednesday: CPI, and Oil Inventory report, Thursday: Building Permits, Housing Starts, Industrial Production, Cap
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
acity Utilization, Unemployment Claims, and Philadelphia Fed, Friday: None. The variabilities of monthly economic reports should contribute to volatility.
Large
Large
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
cap stocks have lagged small cap stocks over the past few years. However, large caps may soon outperform small caps. Also, many industries will benefit from lower
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
oil and gasoline prices. and many stocks in those industries will continue to rise, while "second-tier" stocks catch-up. Moreover, volatility may pick-up, short-
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
term, while the market consolidates.
Charts available at PeakTrader.com Forum Index Market Overview section
Charts available at PeakTrader.com Forum Index Market Overview section
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.wiki-articles.org.ua/article/117765/wiki-articles-SPX-Recreating-the-April-Rally.html">SPX: Recreating the April Rally</a>
BB link (for phorums):
[url=http://www.wiki-articles.org.ua/article/117765/wiki-articles-SPX-Recreating-the-April-Rally.html]SPX: Recreating the April Rally[/url]
Related Articles:
22 Ways to Increase Your E-zine Subscriber List
Ten Fatal Mistakes That Make Web Sites Stink
Bookmark it:
|